文献速递临床试验与 GCP基础与转化研究

数字干预对巴西和秘鲁合并高血压或糖尿病患者的抑郁症状效果:两项随机临床试验

Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
PubMed 文献 · JAMA · 2021-01-01

在巴西圣保罗(整群随机,N=880)和秘鲁利马(个体随机,N=432)的两项随机临床试验中,针对合并高血压和/或糖尿病且PHQ-9≥10的患者,6周数字干预(基于行为激活原则,由护士助理支持)相比强化常规照护,在3个月时显著提高PHQ-9评分降低≥50%的比例。巴西组差异为12.1个百分点(95%CI 5.5-18.7),秘鲁组为18.6个百分点(95%CI 9.1-28.0);但6个月时组间差异不再有统计学意义。

要点

  • 数字干预可短期改善合并高血压/糖尿病患者的抑郁症状。
  • 3个月时PHQ-9降低≥50%的比例干预组更高。
  • 6个月时效果未持续,组间差异无统计学意义。

核心结论

  • 在巴西和秘鲁的两项随机临床试验中,6周数字干预相比强化常规照护显著改善了3个月时的抑郁症状,但巴西试验效应量较小且效果未在6个月时维持。

研究设计与样本

  • 巴西圣保罗开展整群随机临床试验,纳入20个站点880例患者,随机分为数字干预组(10群组440例)和强化常规照护组(10群组440例)。
  • 秘鲁利马开展个体水平随机临床试验,纳入7个站点432例患者,随机分为数字干预组217例和强化常规照护组215例。
  • 纳入标准为正在接受高血压和/或糖尿病治疗且PHQ-9评分≥10的临床显著抑郁症状患者。

主要发现

  • 6个月随访时组间差异不再有统计学意义。

关键数值与推荐

  • 主要结局为3个月时PHQ-9评分较基线降低≥50%,PHQ-9评分范围0-27,分数越高抑郁越严重。
  • 次要结局包括6个月时PHQ-9评分较基线降低≥50%。

临床怎么用

  • 对于合并高血压或糖尿病且PHQ-9≥10的患者,可考虑提供6周低强度数字干预以短期改善抑郁症状。
  • 需注意干预效果在6个月时未持续,可能需要加强后续支持或延长干预。

局限性

  • 巴西试验中效应量较小。
  • 效果未在6个月时维持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Depression is a leading contributor to disease burden globally. Digital mental health interventions can address the treatment gap in low- and middle-income countries, but the effectiveness in these countries is unknown. OBJECTIVE: To investigate the effectiveness of a digital intervention in reducing depressive symptoms among people with diabetes and/or hypertension. DESIGN, SETTING, AND PARTICIPANTS: Participants with clinically significant depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] score ≥10) who were being treated for hypertension and/or diabetes were enrolled in a cluster randomized clinical trial (RCT) at 20 sites in São Paulo, Brazil (N=880; from September 2016 to September 2017; final follow-up, April 2018), and in an individual-level RCT at 7 sites in Lima, Peru (N=432; from January 2017 to September 2017; final follow-up, March 2018). INTERVENTIONS: An 18-session, low-intensity, digital intervention was delivered over 6 weeks via a provided smartphone, based on behavioral activation principles, and supported by nurse assistants (n = 440 participants in 10 clusters in São Paulo; n = 217 participants in Lima) vs enhanced usual care (n = 440 participants in 10 clusters in São Paulo; n = 215 participants in Lima). MAIN OUTCOMES AND MEASURES: The primary outcome was a reduction of at least 50% from baseline in PHQ-9 scores (range, 0-27; higher score indicates more severe depression) at 3 months. Secondary outcomes included a reduction of at least 50% from baseline PHQ-9 scores at 6 months. RESULTS: Among 880 patients cluster randomized in Brazil (mean age, 56.0 years; 761 [86.5%] women) and 432 patients individually randomized in Peru (mean age, 59.7 years; 352 [81.5%] women), 807 (91.7%) in Brazil and 426 (98.6%) in Peru completed at least 1 follow-up assessment. The proportion of participants in São Paulo with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 40.7% (159/391 participants) in the digital intervention group vs 28.6% (114/399 participants) in the enhanced usual care group (difference, 12.1 percentage points [95% CI, 5.5 to 18.7]; adjusted odds ratio [OR], 1.6 [95% CI, 1.2 to 2.2]; P = .001). In Lima, the proportion of participants with a reduction in PHQ-9 score of at least 50% at 3-month follow-up was 52.7% (108/205 participants) in the digital intervention group vs 34.1% (70/205 participants) in the enhanced usual care group (difference, 18.6 percentage points [95% CI, 9.1 to 28.0]; adjusted OR, 2.1 [95% CI, 1.4 to 3.2]; P < .001). At 6-month follow-up, differences across groups were no longer statistically significant. CONCLUSIONS AND RELEVANCE: In 2 RCTs of patients with hypertension or diabetes and depressive symptoms in Brazil and Peru, a digital intervention delivered over a 6-week period significantly improved depressive symptoms at 3 months when compared with enhanced usual care. However, the magnitude of the effect was small in the trial from Brazil and the effects were not sustained at 6 months. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02846662 (São Paulo) and NCT03026426 (Lima).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Araya R, Menezes PR, Claro HG, et al. Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials. JAMA. 2021. PMID: 33974019. doi:10.1001/jama.2021.4348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。